Additionally, fumosorinone, a terpene compound isolated from the same fungal species, could act as a classic non-competitive inhibitor of protein tyrosine phosphatase 1B (PTP1B), indicating that the compound could function in medicine for the clinical treatment of diabetes (type II) and other related metabolic disorders (Liu et al., 2015). This evidence concerns the gene PTPN1 and Other metabolic disease.